A Phase II Study of Sorafenib in Patients with Platinum-Pretreated, Advanced (Stage IIIb or IV) Non-Small Cell Lung Cancer with a KRAS Mutation

Anne-Marie C. Dingemans, Wouter W. Mellema, Harry J. M. Groen, Atie van Wijk, Sjaak A. Burgers, Peter W. A. Kunst, Erik Thunnissen, Danielle A. M. Heideman, Egbert F. Smit

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)743-751
JournalClinical Cancer Research
Issue number3
Publication statusPublished - 1 Feb 2013

Cite this